DocGo Company Leadership
| DCGO Stock | USD 0.92 0.01 1.08% |
DocGo employs about 3.4 K people. The company is managed by 17 executives with a total tenure of roughly 7943 years, averaging almost 467.0 years of service per executive, having 200.24 employees per reported executive. Analysis of DocGo's management performance can provide insight into the firm performance.
DocGo Management Team Effectiveness
The company has return on total asset (ROA) of (0.0947) % which means that it has lost $0.0947 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2107) %, meaning that it created substantial loss on money invested by shareholders. DocGo's management efficiency ratios could be used to measure how well DocGo manages its routine affairs as well as how well it operates its assets and liabilities.DocGo Workforce Comparison
DocGo Inc is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 5,458. DocGo totals roughly 3,404 in number of employees claiming about 62% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.36) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.36. DocGo Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DocGo insiders, such as employees or executives, is commonly permitted as long as it does not rely on DocGo's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, DocGo insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Lee Bienstock over two weeks ago Disposition of 18598 shares by Lee Bienstock of DocGo at 3.35 subject to Rule 16b-3 | ||
Ely Tendler over three months ago Disposition of 10000 shares by Ely Tendler of DocGo at 1.59 subject to Rule 16b-3 | ||
Lee Bienstock over three months ago Disposition of 18597 shares by Lee Bienstock of DocGo at 1.52 subject to Rule 16b-3 | ||
Lee Bienstock over six months ago Acquisition by Lee Bienstock of 15000 shares of DocGo at 1.54 subject to Rule 16b-3 | ||
Stanley Vashovsky over six months ago Disposition of 1500000 shares by Stanley Vashovsky of DocGo subject to Rule 16b-3 | ||
Lee Bienstock over six months ago Disposition of 59360 shares by Lee Bienstock of DocGo at 3.03 subject to Rule 16b-3 | ||
Lee Bienstock over six months ago Disposition of 18598 shares by Lee Bienstock of DocGo at 4.23 subject to Rule 16b-3 | ||
Leite Etalvina over six months ago Disposition of 16500 shares by Leite Etalvina of DocGo at 4.34 subject to Rule 16b-3 |
DocGo Notable Stakeholders
A DocGo stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DocGo often face trade-offs trying to please all of them. DocGo's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DocGo's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| James MD | CEO Board | Profile | |
| Stanley Vashovsky | CoFounder Chairman | Profile | |
| Norman Rosenberg | Treasurer CFO | Profile | |
| Ben Sherman | EVP Development | Profile | |
| Anthony Capone | President | Profile | |
| Ely Tendler | Secretary Counsel | Profile | |
| Aaron Severs | Chief Officer | Profile | |
| Mike Cole | Vice Relations | Profile | |
| Lee Bienstock | Chief Officer | Profile | |
| Andre CPA | Executive Strategy | Profile | |
| Mark Merlin | LLC Holdings | Profile | |
| Ely JD | Secretary Counsel | Profile | |
| Stephen Sugrue | Chief Officer | Profile | |
| Vrenely Munoz | Chief Officer | Profile | |
| Eiwe Lingefors | Chief Officer | Profile | |
| Stan Vashovsky | Chairman CoFounder | Profile | |
| Rosemarie Milano | Vice Resources | Profile |
About DocGo Management Performance
The success or failure of an entity such as DocGo Inc often depends on how effective the management is. DocGo management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DocGo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DocGo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York. Docgo operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 1706 people.
DocGo Workforce Analysis
Traditionally, organizations such as DocGo use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DocGo within its industry.DocGo Manpower Efficiency
Return on DocGo Manpower
| Revenue Per Employee | 181.1K | |
| Revenue Per Executive | 36.3M | |
| Net Income Per Employee | 5.9K | |
| Net Income Per Executive | 1.2M | |
| Working Capital Per Employee | 53.7K | |
| Working Capital Per Executive | 10.7M |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DocGo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DocGo. If investors know DocGo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DocGo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of DocGo Inc is measured differently than its book value, which is the value of DocGo that is recorded on the company's balance sheet. Investors also form their own opinion of DocGo's value that differs from its market value or its book value, called intrinsic value, which is DocGo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DocGo's market value can be influenced by many factors that don't directly affect DocGo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DocGo's value and its price as these two are different measures arrived at by different means. Investors typically determine if DocGo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DocGo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.